Too much cholesterol in the blood, or high blood cholesterol, can be serious. People with high blood cholesterol have a greater chance of getting heart disease. High blood cholesterol itself does not cause symptoms, so many people are unaware that their cholesterol level is too high.
Lipitor safer for cholesterol patients
Cholesterol :: Lipitor safer for cholesterol patients
An observational study of a large United Kingdom primary care database showed that switching patients from Pfizer?s Lipitor? (atorvastatin calcium) Tablets to simvastatin was associated with a 30 percent increase in the relative risk of major cardiovascular events, including heart attacks, strokes and certain types of heart surgeries, or death compared to patients who remained on Lipitor therapy.The data, which included records from October 1997 to June 2005, were generated from a retrospective analysis of a medical database of anonymous patient records entered by general practitioners in the United Kingdom known as The Health Improvement Network (THIN). The analysis included 11,520 patients (2,511 patients who had taken Lipitor for six months or more and were switched to simvastatin vs. 9,009 patients who were taking Lipitor for six months or more and then remained on Lipitor therapy). Reasons for switching were not available from the database. Since patients were not randomly assigned to each group, the two treatment groups were matched based on certain risk factors and statistical adjustments were made to address any residual imbalances. As with all observational studies, the findings should be regarded as hypothesis generating.
?Today, many health care payors including governments and managed care companies are encouraging patients who are well-established on one therapy to switch to a different statin therapy,? said Dr. Michael Berelowitz, senior vice president of Pfizer?s global medical division. ?This study raises concerns about those policies. It suggests the potential for poorer cardiovascular outcomes associated with switching patients from established Lipitor therapy to simvastatin.?
A secondary analysis of the same data showed that patients who were switched from Lipitor to simvastatin were more than twice as likely to discontinue their treatment compared to those who remained on Lipitor therapy (20.5 percent versus 7.62 percent, p<0.001). The reasons for discontinuation were not available from the database, though disruption in treatment has been associated with poor adherence in previous studies of statins and other medications.
?The results of this analysis complement the large body of evidence from multiple clinical trials demonstrating the cardiovascular benefits of Lipitor,? said Dr. Berelowitz. ?Observational studies help the medical community better appreciate what is really happening in doctors? offices, and are commonly used by healthcare payors to set medical practice guidelines. This analysis highlights the need to carefully consider individual patient circumstances and cardiovascular risk because indiscriminate switching may adversely affect some patients.?
Additional Study Information
The primary endpoint was time to a first major cardiovascular event, defined as heart attack, stroke, or coronary revascularization (a type of heart surgery), or all-cause death. There was a statistically significant 30 percent increase in the relative risk of the primary endpoint (p=0.03).
The individual components making up the primary endpoint were analyzed as secondary endpoints. Compared with patients who did not switch therapy, switching was associated with the following:
- Significant 43 percent increase in the relative risk of major cardiovascular events (p=0.008)
- No difference in all-cause death (p=0.369)
The two treatment groups were matched based on the following: gender, history of heart attack, diabetes, time since last statin exposure and general practitioner treatment center.
The following statistical adjustments were made to address any residual imbalances: age, gender, prior statin exposure, time since last statin exposure, diabetes, history of heart attack, and baseline cholesterol levels.
Relative risk is the ratio of the risk of major cardiovascular events or death occurring in the group who switched from Lipitor to simvastatin versus the risk in the group who remained on Lipitor.
(Cholesterol :: Lipitor safer for cholesterol patients published at SpiritIndia on Wednesday, September 5, 2007)
Cholesterol
Search more information on Cholesterol, Cholesterol booksRecently posted related articles on Cholesterol :
- Cholesterol :: Atrogin breaks down the side effects of statins
- Cholesterol :: Contribution of cholesterol transporter to vascular disease
- Cholesterol :: MIT links gene to cholesterol
- Cholesterol :: Corazonas Foods & Brandeis University partner to create cholesterol reducing snacks
- Cholesterol :: Canola oil increases compliance with dietary recommendations for fatty acids
- Premature Birth :: Low maternal cholesterol tied to premature birth
- Cholesterol :: Older American women better informed about cholesterol than younger women
- Cholesterol :: Cholesterol byproduct blocks heart health benefits of estrogen
- Cholesterol :: Cholesterol tests advised at 15 months of age
- Cholesterol :: Lipitor safer for cholesterol patients
Most related articles:
- Cholesterol :: Lipitor safer for cholesterol patients- Cholesterol :: Statins lowers cholesterol, improves kidneys - 13.4
- Heart Attack :: Health Canada approves Lipitor to reduce heart attack risk in coronary heart disease patients - 12.9
- Cholesterol :: Cholesterol drugs, statins, Lipitor over-prescribed - The Lancet - 12.9
- Cholesterol :: Raise Good Cholesterol Levels - 12.8
- Lipitor :: Pfizer's Lipitor Data at the American College of Cardiology Meeting - 12.2
- Cholesterol :: Alfalfa and High cholesterol - 11.4
- Cholesterol :: Canadian Federal Court Upholds Lipitor Patent - 11.2
- Cholesterol :: Controlling Cholesterol the Natural Way - 11.1
- Cholesterol :: Lipitor significantly reduced cardiovascular risk - 11
- Hypertension :: High blood pressure means high cholesterol - 10.9
Cholesterol - recent related articles/news stories:
- Oxycholesterol cholesterol may pose greatest heart disease risk- Statins may cause muscle damage in some patients
- Red yeast rice reduce cholesterol in statin intolerant
- Plant based low carb diet promotes weight loss
- Statins may help prevent stroke recurrence
»» Heart Disease :: Environmental stress probed in heart disease, diabetes
«« Insulin :: Sugary drinks, not fruit juice, may be linked to insulin
The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com